Regulatory Challenges in Commercialization of Novel Biologics for Tissue Regeneration

Esmaiel Jabbari1

  • 1University of South Carolina

Details

11:00 - 12:00 | Thu 10 Nov | Maya IV - V | ThSPS.3

Session: Special Panel Session Bench to Market: Standards and Regulatory Considerations

Abstract

The revolutionary CortiaMic device is a spinal fusion solution that provides the strength and stability of current plastic and metal products and is ultimately displaced by the patient's own bone tissue. The objective was to demonstrate feasibility for the transfer of CortiaMic technology from bench to commercial scale.